2/21/2025

Corporations Embrace Shareholder Activism, Accepting Proposals from Quad Asset Management

Chosun Biz (South Korea) (02/21/25) Jung-a, Kang

Ahead of the regular annual shareholders' meeting season in March, shareholder activism is intensifying, and listed companies have begun to accept this and announce shareholder return measures. The first results this year came from the first-generation Korean hedge fund, Quad Asset Management. Following the shareholder letter sent to Korea Electric Terminal (025540) by Quad Asset Management, the company announced a corporate value enhancement disclosure. In addition, asset managers and minority shareholder alliances are expected to engage in a fierce competition for votes at the regular shareholders' meeting as they make shareholder proposals to companies such as Coway (021240). Connector manufacturer Korea Electric Terminal announced a value enhancement disclosure on the 17th of this month and stated that it would expand the total shareholder return rate to 30% of its annual consolidated net profit by 2026 through stock buybacks and retirements. The company also plans to regularize communication with investors and shareholders. In particular, Korea Electric Terminal received attention by announcing plans to incorporate its affiliate KT as a subsidiary by 2027. This was a request made by Quad Asset Management, which holds about 3% of Korea Electric Terminal's equity, through a shareholder letter last month. Quad Asset Management has claimed that Korea Electric Terminal has been infringing on shareholders' interests by funneling business to KT. According to Quad Asset Management, 86% of KT's product purchases are generated from internal transactions with Korea Electric Terminal. In response, Quad Asset Management demanded the following from Korea Electric Terminal: A merger with KT; an increase of the dividend payout ratio to over 35%; and enhanced communication with shareholders. Korea Electric Terminal decided to incorporate KT as a subsidiary rather than merging with it, and set the dividend payout ratio at 30%. Most of Quad Asset Management's demands have reportedly been accepted. A representative from Quad Asset Management noted, "The company also felt the need for change" and said that "a significant portion of the requested items has been accepted." In addition, this year, activist funds Align Partners and Singapore's Flashlight Capital Partners (FCP) are conducting shareholder activism campaigns against Coway and KT&G, respectively. Minority shareholder alliances from Lotte Shopping and Emart have also proposed the introduction of concentrated voting systems and improvements in governance. Securities industry officials see a high likelihood of activist campaigns occurring in companies with low major shareholder equity and low shareholder return rates. According to IBK Securities, out of seven companies engaged by shareholder activism campaigns as of early February this year, six had major shareholder equity below 50%. Also, there were four companies whose shareholder return rate did not reach 30% in the previous year. Kwon Sun-ho, a researcher at IBK Securities, stated, "Activist campaigns tend to occur more in value stocks than in growth stocks," adding that "the lower the major shareholder's equity, the more participation from minority shareholder alliances and institutional investors can increase the likelihood of agenda items being presented and approved at the shareholders' meeting."

Read the article

2/21/2025

GSK’s Sluggish Shares Seen at Risk of New Activist Campaign

Bloomberg (02/21/25) Pham, Lisa; Campling, Neil

GSK Plc (GSK) is a long-term underperformer among Europe’s Big Pharma stocks. And with key drug patents set to expire and vaccine sales falling, some market participants say it may draw in activist investors again. Shares in the British drugmaker have fallen about 19% since it spun off its consumer health business in 2022, a move that activists had supported. Analyst sentiment has been turning more negative, as patents for medicines including HIV treatment dolutegravir are set to expire in coming years. GSK said this month that it’s making progress in late-stage development of several oncology drugs, though vaccine sales are falling. “There needs to be material progress on the pipeline or successful M&A to help address the chronic long-term underperformance of the share price,” said Ketan Patel, fund manager at the family office Whitefriars. In the meantime, “activist investors will be knocking on the front door.” GSK previously received engagement from Elliott Investment Management and Bluebell Capital Partners. While both broadly agreed with the company’s plans to spin off its consumer-health unit, they questioned whether Chief Executive Officer Emma Walmsley was the right leader for GSK. Even so, she has remained at the helm. During Walmsley’s near eight-year tenure, GSK shares have delivered a total annualized return of about 3%, compared with more than 7% for peers, according to data compiled by Bloomberg. GSK has also trailed the UK’s benchmark FTSE 100 Index during this time, while AstraZeneca Plc has gone on to become the UK’s biggest company by market value. “We believe the current situation at GSK is ripe for an activist to shake up the business given the chronic underperformance compared to chief rival AstraZeneca,” said Emmanuel Valavanis, senior vice president of equity sales at Forte Securities. That could take the form of M&A, a carve out of the vaccines business or a push for more shareholder returns, he said. Dominic Rose, an analyst at Intron Health, also sees shareholder activism as a possibility given GSK’s share-price underperformance. “If activists were to step in, they might push for a sharper strategic focus — potentially advocating for a pure-play vaccines business,” he said. Rose also highlighted operational efficiencies, pipeline acceleration, or capital allocation adjustments as other potential angles. According to David Redfern, president of corporate development at GSK, shareholders “are very aligned” with what the drugmaker is doing. “We’re pretty focused around building a bigger specialty business, we’re focused around our main product areas,” Redfern said in an interview. “I think all of that is supported — they really just want to see ongoing execution.” The looming patent expiries and concerns about vaccine sales have kept analysts fairly cautious on the stock. GSK’s consensus analyst rating — a proxy for the ratio of buy, hold, and sell recommendations — is currently at 3.27, according to data compiled by Bloomberg. That’s the lowest score in more than five years, and less than all other major European pharmaceutical companies. GSK shares fell as much as 3.1% to 1,402.5 pence on Friday morning. GSK’s new forecast is up from the more than £33 billion it had predicted in 2021. The firm is optimistic about generating sales from drugs it has in development, as well as the potential re-launch of its blood cancer drug Blenrep this year. The shares have also been under pressure in recent years because of ongoing litigation over GSK’s old reflux medication, Zantac. The company agreed last year to pay as much as $2.2 billion to resolve the vast majority of court cases. All of this has left GSK trading relatively cheaply. The stock’s multiple of about 8.4 times estimated earnings compares with AstraZeneca at about 16 times and is roughly half that of the Stoxx 600 Health Care Index. GSK is “cheap but challenges persist,” Sarita Kapila, an analyst at Morgan Stanley, wrote in a recent note. The valuation largely reflects longer-term growth challenges, as well as “the lack of innovation momentum in 2025.” Despite the pessimism, GSK continues to attract investors looking for steady capital returns. The drugmaker’s 12-month dividend yield is the highest among peers, while the £2 billion buyback announced this month is the company’s first stock repurchase program in more than a decade. For Nick Kirrage, a fund manager at Schroders Plc, GSK has done “really good work” in terms of restructuring its business. “They now just have to deliver on the R&D,” he said. “And I think if you wait five years, they will.”

Read the article

2/20/2025

Southwest's Layoffs Dent its Worker-first Culture

Reuters (02/20/25) Singh, Rajesh Kumar

Southwest Airlines' (LUV) first company-wide layoffs in its nearly 54-year history are aimed at shoring up profits, but they run the risk of undermining a company culture of putting employees first that made it stand out from rivals and cultivated a loyal fan base. Until this week, the U.S. carrier never resorted to mass layoffs and furloughs, even as the industry underwent crushing downturns. But soaring costs and sagging profits forced its hand on Monday to announce that it will slash 1,750 jobs, or 15% of its corporate workforce. Conor Cunningham, an analyst at Melius, said the layoffs go against the company's long-built culture, which he described as "the special sauce that makes everything possible." The layoffs also reflect a new reality at Southwest, where Elliott Investment Management's nominees currently hold five of 15 board seats and CEO Bob Jordan is under pressure to produce a fast turnaround. At meetings with Southwest's unions last year, Elliott had emphasized the need to "right-size" the company's headquarters, according to a person who attended the meeting. Jordan has outlined a strategy that seeks to lift Southwest's operating margin to at least 10% in 2027 from 2% last year. Robert Mann, a former airline executive who now runs a consulting firm, said the job cuts suggest there is a greater urgency to deliver on those goals. "It's a nod to the pressure that they're under from Elliott," Mann said. Southwest said while the layoff decision was "extremely difficult," it has tried to provide support and care to the affected employees. "The strength of Southwest's culture is critical to the success of our business and our ability to serve our customers," the airline said in a statement. "Our people will continue to be what sets us apart as we drive the company forward." He also said would consider imposing it for a longer period. Lackluster profits coupled with falling shares brought Elliott to Southwest's doorstep last year. The hedge fund launched a bitter boardroom battle, calling for new leadership and wholesale changes to its business. A truce last October allowed Jordan to keep his job. But the "cooperation" agreement between Southwest and Elliott is due to end next year. Other developments also point to the activist investor's growing influence. On Wednesday, Southwest said its agreement with Elliott has been amended to allow the hedge fund to increase its maximum allowable stake to 19.9% from the previous limit of 14.9%. The company also said Chief Transformation Officer Ryan Green, who was entrusted with rolling out the turnaround plan, will step down on April 1. His exit follows the departures of Chief Financial Officer Tammy Romo and Chief Administration Officer Linda Rutherford. Since 1971 when the airline started operations, it has operated with a philosophy that happier employees result in happier customers. In the past, the company relied on early retirements and natural attrition to deal with overstaffing. Southwest's headcount declined by over 2,300 to 72,450 employees in 2024 through natural attrition. Doug Parker, former CEO of rival American Airlines (AAL), last year said Southwest enjoyed a competitive advantage with airline customers because of its culture. He warned that changes to the company's culture would be bad for its shareholders. Jordan has called Monday's announcement a "monumental shift." In a staff memo on Wednesday, he cited it as an example of how the company must change to maintain its competitive advantage. Southwest has set a target to generate over $500 million in annual cost savings by 2027. Last month, Southwest told investors it was looking to hit that goal "as quickly as possible" and signaled plans to target its corporate overhead. Its corporate headcount has increased 28% since 2019, faster than the 19% growth in the airline's total headcount. In comparison, its fleet and seat capacity increased by 7% and 13%, respectively. Southwest said the workforce reduction would save it $210 million this year and $300 million next year. The layoffs do not affect frontline workers such as pilots and flight attendants. But in a note to members, the head of Southwest's flight attendant union said the news had created uncertainty for all. One of Southwest's pilots called it the beginning of the end of the company's famed culture. Several employees took to social media, seeking help for their colleagues.

Read the article

2/19/2025

Activist Boom in Japan Is Upending Long-Short Stock Strategies

Bloomberg (02/19/25) Yokoyama, Momoka

Takeover bids and activist intervention are shoring up shares of some Japanese companies seen as having weak fundamentals, making it harder for investors to succeed in short-selling strategies. Hints of the difficulty are starting to show in trading data. Japan’s percentage of short-selling to total trades is at the lowest since July last year, in terms of the 60-day moving average. With mergers and acquisitions reaching a record of more than $230 billion last year in the country, and activists exerting greater influence on corporate Japan, investors from Sparx Asset Management to UBP Investments Co. and Sigmoid Capital are becoming warier of non-earnings factors that may boost shares. “Even when I expect shares to fall, depending on their financial condition or shareholder structure they still could be a target,” said Takuya Haruo, a fund manager at Sparx Asset Management,. “I cannot call it before it happens but I need to take into account the possibility.” Haruo, who oversees the Sparx Japan Equity Long Short Fund, closed two out of three short positions on automakers after plans to combine Honda Motor Co. (HMC) and Nissan Motor Co. (NSANY) came out in December. While they have since called off talks, a surge in M&As has Haruo scrutinizing the financial positions and shareholder structures of short targets. The changing landscape also prompted Zuhair Khan, a fund manager at UBP Investments, to avoid shorting cash-heavy companies and real estate-rich firms that may become targets for activist investors. His previous strategy consisted of taking short positions betting that shares would fall once activist proposals failed. Khan is now going long on companies that he thinks are likely to be taken over. Three of his long positions over the past seven months were the targets of takeover bids, amid growing pressure from the economic ministry and the Tokyo Stock Exchange to boost shareholder value. “There’s been dynamic changes in governance,” said Khan, who oversees $76 million in investments focused on whether companies are managed properly. “All of that has definitely had an impact on how and which stocks we select to go long and short.” The fund manager is maintaining his portfolio’s short exposure as he remains ready to short companies left with high valuations after Japan’s equity market surged more than 40% over the past two years. Firms that hold low profit margin businesses are also targets to sell, he said. Sparx’s Haruo is still looking for opportunities to sell overvalued blue-chip stocks. Meanwhile, he has built a stake in Seven & i Holdings Co. (SVNDY) for its fundamentals and prospects the shares will rise regardless of whether the takeover bid by Alimentation Couche-Tard Inc. (ANCTF) or the competing plan by the company’s management succeeds. He said his net exposure — the difference between a fund’s long positions and its short positions — will be maintained at about 30%. Equity ownership of management and a company’s operational track record are factors to look at when picking shorts, said Wendy Chen, founder and chief investment officer of Sigmoid Capital. Her fund avoids shorting automakers because of their low price-to-book ratio, which tends to attract activists. But non-fundamental factors are not unique to Japan, according to Chen, who manages $100 million in fund assets. “If you compare Japan to its own history, it was simpler before and now there’s this additional factor you have to consider,” Chen said. “There’s always some sort of non-fundamental factors in each of market.” For Japan, those factors include buybacks and other corporate actions, said Masanari Takada, a quantitative and derivatives strategist at JPMorgan Securities Japan Co. That makes it harder to choose the right short, he said. “If there are stocks that look promising in the long term, I think it’s a good idea to go long, but the question of what to short always comes up,” Takada said. “There remains the possibility of long-short strategies becoming quite difficult to manage.”

Read the article

2/19/2025

Megacap-chasing Activist Investors Set Sights on SoftBank, Disney, Pfizer

Nikkei Asia (02/19/25) Tsutsumi, Kentaro

Activist funds posting strong returns and expanding with institutional investors' backing are increasingly homing in on megacap stocks and companies verging on that status in the U.S., Japan and beyond, going after the likes of Disney (DIS), Pfizer (PFE), and SoftBank Group (SFTBY). At an investor conference in November, Pfizer CFO David Denton said in response to a question about activist investors that the U.S. pharmaceutical company is constantly examining its business model to see if any of its assets would be better served outside the company than inside. "If we had an asset that felt better out, we would look to monetize that," Denton said. "At some level, we're going to de-lever in the near term anyhow," he said. "Our business is on a trajectory to do that." Pfizer's market capitalization is approximately $145 billion. Starboard Value in October was revealed to have acquired a Pfizer stake. The U.S. hedge fund reportedly has concerns about Pfizer's track record in mergers and acquisitions and in research and development, and the two companies are at odds over management policies. Activist investors in 2024 began a flurry of campaigns against megacap companies, defined as those with market capitalizations above $100 billion. The Walt Disney Co., with a market cap of approximately $200 billion, received shareholder proposals from Trian Partners and Blackwells Capital, which wanted to appoint directors. Disney won the proxy battle at its general shareholders meeting that April but spent roughly $40 million on advertising and other outreach. Even in Japan, where activism has traditionally focused on small- and midcap stocks, activist investing in megacaps is becoming more noticeable. Elliott Investment Management in June was revealed to have rebuilt a stake in SoftBank Group, which has a market cap of 14 trillion yen (about $92 billion), calling on the Japanese company to launch a stock buyback. Elliott has also invested in Sumitomo Corp. (SSUMY), whose market cap is 4 trillion yen; Mitsui Fudosan (MTSFY), at 3.6 trillion yen; and Tokyo Gas (TKGSY) at 1.8 trillion yen. Palliser Capital is calling on resource major Rio Tinto (RTNTF) to do away with its dual-listing structure in the U.K. and Australia and unify as a holding company with Australia as its primary market. The London-based fund announced in December that it had submitted a proposal in collaboration with more than 100 shareholders. In 2024, 1,625 activist campaigns were underway worldwide, including shareholder proposals filed by parties other than activist funds, according to strategy consultancy EY-Parthenon. This was the highest figure ever, topping the 1,579 of 2023. Of the 1,625 cases, 455, or 28% of the total, engaged companies with market caps exceeding $100 billion. This was another record high, up from 17% in 2021. In particular, there was a large increase in campaigns engaging companies with market caps above $200 billion, from 9% to 19% of the whole. Companies with large market caps have a high proportion of institutional investors among their shareholders, making it easier to get proposals approved. In addition to high stock liquidity, these companies are also well-covered in the news media, again making it easier for activists to wage their battles. One factor behind this trend is the increasing size of funds' assets under management. "Activist funds are performing well, and capital inflows from institutional investors continue," said Manabu Shinohara, strategy and transformation leader at EY Japan. According to an index calculated by U.S.-based Hedge Fund Research engaging major funds around the world, activist funds have posted 96% returns over the past 10 years, far exceeding the 58% overall return of hedge funds. The market value of shares held by 30 major activist funds came to about $230 billion as of December, up 50% from 10 years earlier, according to QUICK FactSet. "North American pension funds and others are increasingly looking to activists and engagement funds that will help improve the corporate value of Japanese companies," said a source at a fund that invests in Japanese companies. The demands being made of companies follow a similar script. "For overseas companies with large market capitalizations, the tendency is for proposals to call for breaking up their conglomerate structure," EY Japan's Shinohara said. "There are also increasing demands for cost reductions."

Read the article

2/19/2025

U.S. Investors to Lead Activist Charge in Europe in 2025, Study Says

Reuters (02/19/25) Revill, John

Activist investors are expected to step up their campaigns across Europe this year, with American firms increasingly involved buying into companies to put pressure on their management, a study said on Wednesday. Low market valuations of European companies make it cheaper for U.S. firms to build stakes and demand changes, according to the report by professional services company Alvarez & Marsal. Last year, 35% of public activist campaigns in Europe were launched by U.S. based funds, up from 27% in 2023, with Britain, Switzerland and Germany, increasingly in their sights. One of Wall Street's most activist investors, Jeffrey Ubben, was made a non-executive director at Bayer (BAYRY) last year, having long urged the German chemicals company to be broken up. "U.S. activists are continuing to make their presence felt in Europe, and this growing appetite shows no sign of subsiding," said Malcolm McKenzie, Chair of European Corporate Transformation Services at A&M. "The UK, Switzerland, and Benelux are already established hunting grounds while Germany is also expected to become a growing target." U.S. activists see a chance to improve performances after European stocks gained an average of 8% last year, lagging the 29% average increase at U.S. companies. The U.S. influx has been particularly marked in Switzerland, where 53% of campaigns since 2020 have been by American-based activists, the study said. Overall, A&M said 141 companies could be at risk of public shareholder activism in Europe over the next 18 months. It declined to identify them. Britain has the most potential targets, with 49 companies, it said, followed by Germany with 33, then Switzerland. "With 17 likely targets, Switzerland is expected to see the largest increase in shareholder activism," said A&M.

Read the article

2/19/2025

Oil’s Activist Threat Takes Shine Off Trump Bump

Bloomberg (02/19/25) Crowley, Kevin

Oil executives expecting U.S. President Donald Trump to usher in four years of wine and roses for the energy industry may want to think again. While his administration is shaping up to be one of the most pro-fossil fuel in recent history, company chiefs face a threat in the form of growing shareholder activism. Recent actions by Elliott Investment Management LP, one of Wall Street’s most-feared activist investors, indicate management teams that fail to outperform may be in the firing line. Such disruptors historically steered clear of the energy sector due to its innate volatility. A perfectly formed turnaround plan can evaporate at the first hint of faltering crude prices. But Elliott, known for withering attacks on underperformers, isn’t deterred this time around. The hedge fund run by Republican donor Paul Singer is calling for major strategic changes at BP Plc (BP), Phillips 66 (PSX) and Tokyo Gas Co. (TKGSY), having successfully pressured Suncor Energy Inc.’s (SU) CEO to step down in 2022. The campaign at BP already appears to be yielding results: The oil major is said to be considering a sale of its lubricants division, according to people familiar with the deliberations. That’s one of the business lines Elliott highlighted as ripe for divestiture. It’s true the industry’s long-term share performance leaves much to be desired. The total return of S&P 500 energy stocks was about 60% during the past decade, compared with almost 250% for the broader index, a symptom of historically poor capital allocation that created gluts of oil and gas. Attempts at diversification, such as BP’s ill-fated move into low-carbon energy, have come under attack by Elliott, which typically demands that companies sell assets and focus on core competencies. “We think of activism as the next leg to address underperforming or antiquated corporate structures,” said Stephen Richardson, an energy analyst at Evercore ISI. “If the entire corporation isn’t of interest to markets or competitors, perhaps a yard sale will be.”

Read the article

2/18/2025

Trump's SEC Leader Shifts Power from Investors to Boardrooms

Reuters (02/18/25) Kerber, Ross

New policies from the top U.S. securities regulator hand corporate boards more power over investors in ways that could curtail investor-initiated reform efforts on everything from climate policy to director contests, experts say. Since last month when U.S. President Donald Trump named Mark Uyeda acting chair of the SEC, the agency has made it easier for boards to block shareholder resolutions, put stricter filing requirements on passive funds, and limit investors' communication abilities. The changes give directors more scope to nix efforts to have companies limit emissions or report workforce diversity details, while traditional activists running their own director slates could also find it harder to challenge boards, attorneys say. "It's a relatively dramatic reallocation of power away from large shareholders back to corporate management, not just to make corporate policy but to protect themselves against activists," said Tulane University business law professor Ann Lipton. Uyeda and other Republican officials, including Paul Atkins, Trump's pick to run the SEC, have made clear their skepticism of ESG investment considerations. The SEC's changes are in line with other Trump administration efforts such as dismantling diversity programs and withdrawing from the Paris Climate Agreement. ESG resolutions drew significant support in 2021 and 2022, but less so since. In a February 11 legal bulletin the SEC made it easier for companies to skip votes on the resolutions such as by claiming the proposals "micromanage" their businesses. That change could make it harder for ESG-minded activists even to start talks with corporate executives. "If it's harder to get your resolution through at the SEC, it will be harder to do that kind of work," said Rick Alexander, CEO of the Shareholder Commons, which tracks and writes resolutions. On Feb. 11, the SEC also revised "beneficial ownership reporting" interpretations to broaden the requirements on firms like asset managers BlackRock (BLK) and Vanguard, which often rely on the SEC's Schedule 13G form to report major holdings. Going forward, the agency tightened when managers can use the form rather than the more complex Schedule 13D, which would increase their costs. A new SEC test is if a company "exerts pressure on management" such as tying director votes to whether a company has a staggered board or poison pill takeover defenses. Proxy voting policies of both BlackRock and Vanguard suggest those circumstances could lead to critical votes. Jessica Strine, CEO of shareholder advisory firm Jasper Street Partners, said the SEC's new interpretation could have a potential downside for companies as well if they cannot know what their top investors think. "It's not a complete gift to management teams if it means they no longer have engagement opportunities with their top shareholders," she said. "That means they don't get to make their case" before votes are cast at annual meetings on matters like executive compensation. A third change involves new guidance on when investors can use the SEC's electronic records system to distribute so-called "exempt solicitations," or communications with other shareholders. Once meant as a tool to reveal closed-door discussions among bigger institutional holders, smaller investors started filing their own exempt solicitations as a cheap way to make their arguments on issues like whether to oppose a certain director or support a shareholder resolution. In a January 27 update the SEC narrowed their permissible use. The documents are "not intended to be the means through which a person disseminates written soliciting material to security holders," the SEC said, but rather only to notify the public of written materials sent to security holders through other means. For Tom Quaadman, Senior Vice President for the U.S. Chamber of Commerce, a top business lobbying group, the SEC's changes were welcome. "You're seeing a rebalancing of SEC policies and rules that are designed to take out special interest activism and bring things back to a focus on investor return," he said.

Read the article

2/18/2025

When Activist Investors Ask for Board Seats

Harvard Business Review (02/18/25) DesJardine, Mark; Tetelbaum, Elina

In June 2024, Elliott Investment Management announced a $1.9 billion investment in Southwest Airlines (LUV). Elliott advocated for strategic changes and leadership replacement, nominating 10 candidates to Southwest’s 15-member board. Just months later, the two parties reached an agreement that included shrinking the board by two seats and appointing six new directors, five of whom were initially proposed by Elliott. The pattern of activists gaining board seats through settlements is not unusual. In recent years, although activists’ success at the ballot box has varied, they have remained successful in influencing the composition of corporate boards and with increased efficiency. In 2024, there were 243 activist campaigns globally, leading to 119 board seats driven by activists. Moreover, in these campaigns, the average days from the public launch of an activism campaign to a formal settlement being reached has decreased dramatically, from approximately six months in 2021 to a few weeks in 2024 (although there is often behind-the-scenes engagement that starts earlier). Given these dynamics, it is necessary for executives, directors, and shareholders to understand activists and their director nominees and how they may influence board dynamics and board effectiveness. Activist-nominated directors can be categorized into two types, based on their affiliations and the nature of their relationships with their activist sponsors. Activist-unaffiliated independent nominees are independent professionals, often armed with industry experience, who are nominated by activist investors claiming they will bring relevant skills and knowledge to boards. They are not employed by, and may have no prior relationships with, the activist fund that nominates them (although some may go on to be nominated multiple times by the same activist). Their backgrounds often include executive roles or public company board experience in relevant sectors to the target company, and they are sometimes identified using an executive search firm rather than sourced through the activist’s personal network. Activist principals are employees or partners of the activist fund itself. Their direct employment aligns their interests closely with the activist’s specific objectives. Often when these individuals join public company boards as part of settlements, such individuals are permitted to share the company’s confidential information with the activist fund. Candidates of either type can find their way onto a board through one of three channels. Given the high stakes of these campaigns and the outcomes that follow, executives and directors need to know how to prepare for and interact with activists and activist board nominees effectively. The first three practices — assess, revamp, and communicate — take place well before an activism campaign manifests. The next three practices — adapt, integrate, and engage — describe reactions when a activism campaign does occur and activist nominees are appointed or elected to a board. By following these practices, executives and directors can ensure better outcomes from hedge fund activism, whatever the circumstances. The nominating and governance committee of a public company board should facilitate regular director self-assessments—sometimes with the help of third parties—of the composition, skills, and effectiveness of the directors. These assessments should help align the directors’ expertise with the company’s strategic vision and the challenges it faces. For instance, a board overseeing a technology company should consider the extent to which it has individuals with knowledge of innovation and emerging technologies. A company navigating complex regulatory changes could evaluate if it might benefit from directors with policy or legal expertise. By treating the board as a strategic asset and aligning its composition with the company’s key opportunities and risks, organizations can identify gaps and preempt vulnerabilities activists might exploit. Any board’s composition should reflect the unique needs of a particular company and be managed so that no critical strategic competency is unaccounted for. For example, when Southwest faced criticism for lacking aviation expertise, Elliott capitalized on this alleged weakness by nominating WestJet’s former CEO. Companies involved in transformative M&A or navigating major regulatory shifts might benefit from having directors with hands-on experience in these areas. A modern, diverse, and well-rounded board not only strengthens decision-making but also undercuts activists’ arguments for change. Transparent communication about the board’s qualifications and alignment with the company’s strategy is essential. Companies should use tools like skills matrices and robust disclosures to demonstrate the depth and diversity of their directors’ expertise. Shareholders must understand that directors bring more than surface-level qualifications; qualities like institutional memory, diplomacy, and strategic oversight are critical to boardroom effectiveness. Activists sometimes try to reduce directors to crude measures, such as age and tenure, but boards that engage and meet with shareholders and clearly articulate the unique contributions of their members can build trust and demonstrate the board’s indispensable role in driving long-term value. When activists are successful in their campaigns, the board should seek to understand what shareholder perspectives and frustrations led them to vote to replace one or more directors. Usually this information could be solicited through direct engagement with shareholders, discussing the topic with the activist-nominated director, or reading through the proxy advisory recommendation reports. Although not always achievable, seeking to understand investor sentiment, including which parts of the company’s strategic plans and priorities failed to resonate with shareholders, will help the board communicate better in the future. Integrating an activist-nominated director requires a clear engagement strategy to ensure their participation is productive and aligned with the company’s strategic vision and the board’s governance norms. A protocol for onboarding new directors should include familiarizing them with the company’s strategy, governance practices, and board processes, including expectations of confidentiality and board decorum. Expectations for constructive collaboration and mutual respect should be communicated and modeled upfront to avoid unnecessary tensions and defensiveness. By facilitating smooth integration, the board can help align everyone toward shared objectives and maintain a cohesive governance structure. To maintain board effectiveness, directors should foster a culture of constructive dialogue where divergent views are respected and debated openly. Once a director joins the board, irrespective of who nominated them, they owe fiduciary duties to the company and all of its stockholders, not only the nominating stockholder. Accordingly, activist-nominated directors may well come to agree with the strategic decisions made by the other board members with the benefit of all the confidential information they were not able to access as an outside party. This approach balances preparedness, collaboration, and strategic focus, ensuring the board can operate effectively and in the best interests of all shareholders, even where an activist has influenced its composition.

Read the article